ICG vs Blue Patent for TAD in cN1 Breast Carcinoma After Neoadjuvant Chemotherapy

Clinical trial NCT06339658 · RECRUITING

Trial details

NCT number: NCT06339658
Sponsor: Hospital Universitari de Bellvitge
Status: RECRUITING
Study type: OBSERVATIONAL

Breast Cancer Axillary Metastases

Start date: 2021-01-01
Primary completion: 2026-01-01
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.